SciELO - Scientific Electronic Library Online

 
vol.46 número2Tratamento de pacientes com úlceras isquêmicas secundárias à esclerose sistêmica com N-acetilcisteína endovenosaSíndrome de Behçet e policondrite recidivante: síndrome MAGIC índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista Brasileira de Reumatologia

versão impressa ISSN 0482-5004versão On-line ISSN 1809-4570

Resumo

SANTIAGO, Mittermayer B.; REIS, Eliana A. G.; LIMA, Isabella  e  REIS, Mitermayer G.. Use of rituximab for the treatment of systemic lupus erythematosus' thrombocytopenia: clinical efficacy and costimulatory molecules effect. Rev. Bras. Reumatol. [online]. 2006, vol.46, n.2, pp.153-156. ISSN 1809-4570.  https://doi.org/10.1590/S0482-50042006000200013.

Thrombocytopenia is not a rare complication in patients with systemic lupus erythematosus (SLE). Its treatment includes the use of corticosteroids, immunosuppressive drugs, intravenous immunoglobulin and, eventually, splenectomy. We describe a SLE patient with persistent thrombocytopenia despite of the use of prednisone and azathioprine that improved after infusion of rituximab (RTX). Flow cytometry analysis revealed depletion of B cells from the peripheral blood as well as a decrease in costimulatory molecules after the administration of the medication. Side effects related to the infusion were not observed. It suggests that RTX may be indicated in selected cases of SLE with thrombocytopenia of difficult control.

Palavras-chave : Systemic lupus erythematosus; thrombocytopenia; rituximab; anti-CD20.

        · resumo em Português     · texto em Português     · Português ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons